MAP2K3 and cervical carcinoma: Downregulation of miR-214 in cervical cancer has been reported by several groups, and miR-214 has been shown to inhibit the growth, migration, and invasion of cervical cancer cells by targeting oncogenes MEK3, JNK1, Plexin-B1, and GALNT7 [15]–[17].